FowlerE, SilverbergJI, FoxJD, et al.Psoriasiform dermatitis after initiation of treatment with dupilumab for atopic dermatitis. Dermatitis, 2019; 30:234–236.
2.
DeGraziaTM, RajiK, AlshamekhS, et al.Psoriatic plaques after initiation of dupilumab therapy. Dermatitis, 2020; 31:e36–e37.
3.
NapolitanoM, ScalvenziM, FabbrociniG, et al.Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: a case series. Dermatol Ther, 2019; 32:e13142.
4.
NapolitanoM, CaiazzoG, FabbrociniG, et al.Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment. Br J Dermatol, 2021; 184(2):341–343.
5.
MirzaFN, WangA, RamachandranSM, et al.Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report. Br J Dermatol, 2021; 185:432–434.
